Food and Drug Administration, 2024
This communication release provides information and recommendations for physicians on discussing overdose prevention and prescribing naloxone for patients with household members who use opioids for any reason.
Topic(s): Medication for Substance Use Disorders
Section: Policy and Practice Resources